Community lists
Samengesteld · Gezondheidszorg

Biotech

Door InspectStocksPublished 14 okt 202619 companies0 followers

Drug developers with approved medicines, built mainly on biologic and genetic science.

Gegroepeerd met hulp van een AI-model en nagekeken door onze redactie. De regel onder elk bedrijf zegt waarom het hier staat.

Sign in to followSign in to copy
Download image
KaartenNiveaus
A
  • GILDGilead Sciences
    US$ 169,73+40,9% 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    US$ 253,39+56,9% 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    US$ 174,35+18,7% 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    US$ 70,71+62,2% 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    US$ 248,18+81,5% 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    US$ 101,69+44,0% 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    US$ 308,82+52,1% 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    US$ 74,52-4,9% 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    US$ 547,02+26,0% 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNYEén stap lager omdat de groei wegebtAlnylam Pharmaceuticals
    US$ 159,80-64,7% 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    US$ 79,53+20,1% 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    US$ 58,32+5,4% 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    US$ 959,45+41,5% 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    US$ 248,70+831,1% 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    US$ 120,64-37,9% 1Y

    Develops and sells therapies for rare lung diseases

  • UTHREén stap lager omdat de groei wegebtUnited Therapeutics
    US$ 595,58+29,0% 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    US$ 122,23+12,9% 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    US$ 259,10+30,1% 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    US$ 87,64-21,5% 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.